Citations

Clear

344 citation(s) found for "ASIRVATHAM, SAMUEL".

Incidence of Idiopathic Ventricular Arrhythmias
Sirichand, Surksha , Killu, Ammar M. , Padmanabhan, Deepak , Hodge, David O. , Chamberlain, Alanna M. , Brady, Peter A. , Packer, Douglas L. , Munger, Thomas M. , Shen, Win-Kuang, Cha, Yong‐Mei , Asirvatham, Samuel J. , Friedman, Paul A. , Mulpuru, Siva K. , Kapa, Suraj , Noseworthy, Peter A. , Gersh, Bernard J. , McLeod, Christopher J. , Asirvatham, Samuel J , Chamberlain, Alanna M

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | February 9, 2017 | Volume: 10 | Issue: 2 | Pages: No page available

10.1161/circep.116.004662 | PMID 28183845 Get It

Background— Ventricular tachycardia and premature ventricular complexes (PVCs) most frequently occur in the context of structural heart disease. However, the burden of idiopathic ventricular arrhythmias (IVA) in the general population is unknown. Methods and Results— We identified incident cases of IVA between 2005 and 2013 from Olmsted County, Minnesota, using the Rochester Epidemiology Project database. For PVC cohorts, we included those with frequent (defined as ≥100 PVC/24 hours) symptomatic PVCs. We defined IVA-associated cardiomyopathy as a drop in ejection fraction of ≥10% from baseline. Between 2005 and 2013, we identified 614 individuals with incident IVA (229 [37.3%] were male; average age was 52.1±17.2 years). Of these, 177 (28.8%) had idiopathic ventricular tachycardia, 408 (66.5%) had symptomatic PVCs, and 29 (4.7%) had IVA-associated cardiomyopathy. The age- and sex-adjusted incidence rates in 2005 to 2007, 2008 to 2010, and 2011 to 2013 were 44.9 per 100 000 (95% confidence interval [CI], 38.0–51.8), 47.6 per 100 000 (95% CI, 40.8–54.5), and 62.0 per 100 000 (95% CI, 54.4–69.6), respectively. In idiopathic ventricular tachycardia, there was an increase in incidence rate with ages ( P <0.001) but not between sexes ( P =0.12). The age-adjusted incidence of symptomatic PVC was higher in females than in males (46.2 per 100 000 [95% CI, 40.9–51.6] versus 20.5 per 100 000 [95% CI, 16.8–24.3]; P <0.001). The small number of individuals with IVA-associated cardiomyopathy precluded any formal testing. Conclusions— The incidence of IVA is increasing. Furthermore, overall incidence increases with age. Although the rate of idiopathic ventricular tachycardia is similar across sexes, women have a higher incidence of symptomatic PVC.
Lead Extraction: The Importance of Preparation and Remaining Opportunities
Padmanabhan, Deepak , Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | February 8, 2017 | Volume: 28 | Issue: 4 | Pages: 474-476

10.1111/jce.13173 | PMID 28176412 Get It

Magnetic Resonance Imaging in Nondependent Pacemaker Patients with Pacemakers and Defibrillators with a Nearly Depleted Battery
Okamura, Hideo , Padmanabhan, Deepak , Watson, Robert E. , Dalzell, Connie, Acker, Nancy, Jondal, Mary Lou, ROMME, ABBY L., Cha, Yong‐Mei , Asirvatham, Samuel J. , Felmlee, Joel P. , Friedman, Paul A. , Jondal, Mary, Asirvatham, Samuel J

Mayo Clinic

Pacing and Clinical Electrophysiology | February 7, 2017 | Volume: 40 | Issue: 5 | Pages: 476-481

10.1111/pace.13042 | PMID 28169434 Get It

BackgroundMagnetic resonance imaging (MRI) in patients with non‐MRI‐conditional cardiac implantable electronic devices (CIEDs) has been shown to be safe when performed under closely monitored protocols. However, the safety of MRI in patients with devices with a nearly depleted battery has not been reported.MethodsProspective data were collected between January 2008 and May 2015 in patients with non‐MRI‐conditional CIEDs undergoing clinically indicated MRI under institutional protocol. Patients who were pacemaker dependent were excluded. Patients whose devices were at elective replacement indicator (ERI) at the time of MRI or close to ERI (ERI or replacement for battery depletion within 3 months of scan) were identified through database review and analyzed for clinical events.ResultsMRI scans (n = 569) were performed in 442 patients. Of these, we identified 13 scans performed with a nearly depleted battery in nine patients. All scans with implantable cardioverter defibrillators (ICDs, n = 9) were uneventful. However, two scans with pacemakers close to ERI resulted in a power‐on‐reset (PoR) event. One scan with a pacemaker close to ERI that was programmed to DOO mode reached ERI during MRI and automatically changed to VVI mode. Additionally, one scan with a pacemaker at ERI did not allow programming. All pacemakers with events were implanted before 2005.ConclusionPatients with pacemakers and ICDs with a nearly depleted battery can safely undergo MRI when patients are not pacemaker dependent. Attention should be paid because old devices can result in PoR or ERI during MRI, which may lead to oversensing and inhibition of pacing.
International Survey of Knowledge, Attitude, and Practice of Cardiologists Regarding Prevention and Management of Cardiac Implantable Device Infections
Asirvatham, Samuel, Friedman, Paul, DeSimone, Daniel C. , Chahal, C. Anwar A. , DeSimone, Christopher V. , Baddour, Larry M. , Sohail, M. Rizwan

Mayo Clinic

Open Forum Infectious Diseases | February 2, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw172.1173 Get It

Fascicular Ventricular Arrhythmias
Gaba, Prakriti , Asirvatham, Samuel J. , Kapa, Suraj , DeSimone, Christopher V. , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | January 14, 2017 | Volume: 10 | Issue: 1 | Pages: No page available

10.1161/circep.116.002476 | PMID 28087563 Get It

High‐resolution electrical mapping of porcine gastric slow‐wave propagation from the mucosal surface
Angeli, Timothy R. , Du, Peng , Sathar, Shameer , Asirvatham, S, Farrugia, Gianrico , Windsor, John A. , Cheng, Leo K. , O’Grady, Gregory , Asirvatham, Samuel J. , Paskaranandavadivel, Niranchan , Hall, Andrew , Asirvatham, Samuel J , Angeli-Gordon, Timothy R

Mayo Clinic

Neurogastroenterology & Motility | December 30, 2016 | Volume: 29 | Issue: 5 | Pages: No page available

10.1111/nmo.13010 | PMID 28035728 Get It

AbstractBackgroundGastric motility is coordinated by bioelectrical slow waves, and gastric dysrhythmias are reported in motility disorders. High‐resolution (HR) mapping has advanced the accurate assessment of gastric dysrhythmias, offering promise as a diagnostic technique. However, HR mapping has been restricted to invasive surgical serosal access. This study investigates the feasibility of HR mapping from the gastric mucosal surface.MethodsExperiments were conducted in vivo in 14 weaner pigs. Reference serosal recordings were performed with flexible‐printed‐circuit (FPC) arrays (128‐192 electrodes). Mucosal recordings were performed by two methods: (i) FPC array aligned directly opposite the serosal array, and (ii) cardiac mapping catheter modified for gastric mucosal recordings. Slow‐wave propagation and morphology characteristics were quantified and compared between simultaneous serosal and mucosal recordings.Key ResultsSlow‐wave activity was consistently recorded from the mucosal surface from both electrode arrays. Mucosally recorded slow‐wave propagation was consistent with reference serosal activation pattern, frequency (P≥.3), and velocity (P≥.4). However, mucosally recorded slow‐wave morphology exhibited reduced amplitude (65‐72% reduced, P<.001) and wider downstroke width (18‐31% wider, P≤.02), compared to serosal data. Dysrhythmias were successfully mapped and classified from the mucosal surface, accorded with serosal data, and were consistent with known dysrhythmic mechanisms in the porcine model.Conclusions & InferencesHigh‐resolution gastric electrical mapping was achieved from the mucosal surface, and demonstrated consistent propagation characteristics with serosal data. However, mucosal signal morphology was attenuated, demonstrating necessity for optimized electrode designs and analytical algorithms. This study demonstrates feasibility of endoscopic HR mapping, providing a foundation for advancement of minimally invasive spatiotemporal gastric mapping as a clinical and scientific tool.
Evaluation of a Unique Defibrillation Unit with Dual‐Vector Biphasic Waveform Capabilities: Towards a Miniaturized Defibrillator
Okamura, Hideo , Killu, Ammar M. , Gilles, Emily J., Tri, Jason , Asirvatham, Roshini, LADEWIG, DEJAE J., Suddendorf, Scott H., Powers, Joanne, Wood‐Wentz, Christina M. , Gray, Peter D., RAYMOND, DOUGLAS M., SAVAGE, SHELLEY J., Savage, Walter T., Asirvatham, Samuel J. , Friedman, Paul A. , Powers, Joanne M, Wood-Wentz, Christina M, Bruce, Charles J. , DeSimone, Christopher V. , GRAY, PETER D., Asirvatham, Samuel J

Mayo Clinic

Pacing and Clinical Electrophysiology | December 19, 2016 | Volume: 40 | Issue: 2 | Pages: 108-114

10.1111/pace.12979 | PMID 27990645 Get It

BackgroundAutomated external defibrillators can provide life‐saving therapies to treat ventricular fibrillation. We developed a prototype unit that can deliver a unique shock waveform produced by four independent capacitors that is delivered through two shock vectors, with the rationale of providing more robust shock pathways during emergent defibrillation. We describe the initial testing and feasibility of this unique defibrillation unit, features of which may enable downsizing of current defibrillator devices.MethodsWe tested our defibrillation unit in four large animal models (two canine and two swine) under general anesthesia. Experimental defibrillation thresholds (DFT) were obtained by delivery of a unique waveform shock pulse via a dual‐vector pathway with four defibrillation pads (placed across the chest). DFTs were measured and compared with those of a commercially available biphasic defibrillator (Zoll M series, Zoll Medical, Chelmsford, MA, USA) tested in two different vectors. Shocks were delivered after 10 seconds of stable ventricular fibrillation and the output characteristics and shock outcome recorded. Each defibrillation series used a step‐down to failure protocol to define the defibrillation threshold.ResultsA total of 96 shocks were delivered during ventricular fibrillation in four large animals. In comparison to the Zoll M series, which delivered a single‐vector, biphasic shock, the energy required for successful defibrillation using the unique dual‐vector biphasic waveform did not differ significantly (P = 0.65).ConclusionsOur early findings support the feasibility of a unique external defibrillation unit using a dual‐vector biphasic waveform approach. This warrants further study to leverage this unique concept and work toward a miniaturized, portable shock delivery system.
Expecting the Expected
Asirvatham, Samuel J. , Stevenson, William G. , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | December 13, 2016 | Volume: 9 | Issue: 12 | Pages: No page available

10.1161/circep.116.004726 | PMID 27956435 Get It

Endocardial Device Leads in Patients with Patent Foramen Ovale: Echocardiographic Correlates of Stroke/TIA and Mortality
Ponamgi, Shiva , Vaidya, Vaibhav R. , Noheria, Amit , Hodge, David O. , Slusser, Joshua P. , Ammash, Naser M., Friedman, Paul A. , Asirvatham, Samuel J. , Ponamgi, Shiva P , Bruce, Charles J. , DeSimone, Christopher V. , Rabinstein, Alejandro A. , Asirvatham, Samuel J

Mayo Clinic

Pacing and Clinical Electrophysiology | December 12, 2016 | Volume: 40 | Issue: 3 | Pages: 310-322

10.1111/pace.12985 | PMID 27943333 Get It

BackgroundEchocardiographically detected patent foramen ovale (PFO) has been associated with stroke/transient ischemic attack (TIA) in patients with cardiac implantable electronic devices (CIEDs). We sought to evaluate the relationship between echocardiographic characteristics and risk of stroke/TIA and mortality in CIED patients with PFO.MethodsIn 6,086 device patients, PFO was detected in 319 patients. A baseline echocardiogram was present in 250 patients, with 186 having a follow‐up echocardiogram.ResultsOf 250 patients with a baseline echocardiogram, 9.6% (n = 24) had a stroke/TIA during mean follow‐up of 5.3 ± 3.1 years; and 42% (n = 105) died over 7.1 ± 3.7 years. Atrial septal aneurysm, prominent Eustachian valve, visible shunting across PFO, baseline or change in estimated right ventricular systolic pressure (RVSP)/tricuspid regurgitation (TR), or maximum RVSP were not associated with postimplant stroke/TIA (P > 0.05). An exploratory multivariate analysis using time‐dependent Cox models showed increased hazard of death in patients with increase in TR ≥2 grades (hazard ratio [HR] 1.780, 95% confidence interval [CI] 1.447–2.189, P < 0.0001), or increase in RVSP by >10 mm Hg (HR 2.018, 95% CI 1.593–2.556, P < 0.0001), or maximum RVSP in follow‐up (HR 1.432, 95% CI 1.351–1.516, P < 0.0001). A significant increase (P < 0.001) in TR was also noted during follow‐up.ConclusionsIn patients with CIED and PFO, structural and hemodynamic echocardiographic markers did not predict future stroke/TIA. However, a significantly higher TR or RVSP was associated with higher mortality.